Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study

Performance-based cognitive data were collected using the Cognitive Drug Research System in a study of levomilnacipran extended-release (ER) 40–120 mg/day (NCT01034462) in adults with major depressive disorder. These data were analyzed post-hoc to explore the relationship between cognitive measures,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Clin Psychopharmacol
Main Authors: Wesnes, Keith A., Gommoll, Carl, Chen, Changzheng, Sambunaris, Angelo, McIntyre, Roger S., Harvey, Philip D.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams And Wilkins 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265686/
https://ncbi.nlm.nih.gov/pubmed/27861191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000157
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados